Biomere is a premier nonclinical contract research organization (CRO) that offers a wide range of preclinical research services, including gene therapy, neurology, and genetically modified models. With locations in Worcester, MA and Richmond, CA, as well as facilities in China, Biomere provides global scale and expertise in pharmacokinetics, lead compound screening, efficacy assessment, and more.
Through a recent merger with Joinn Laboratories, Biomere has expanded its international footprint and scientific portfolio, becoming a leading CRO in both North America and China. With a focus on GLP services and a commitment to welfare and laboratory sciences, Biomere is dedicated to supporting clients' needs in the field of nonclinical research.
Generated from the website